Articles tagged with Liver
Researchers at UCI Center for Epigenetics & Metabolism discovered that circadian rhythms significantly impact liver metabolite production, with approximately 60% dependent on the body clock. This finding has implications for understanding obesity, high cholesterol, and metabolic diseases.
Researchers at the University of Southern California have identified the role of stem and progenitor cells in liver regeneration. Bone marrow-derived progenitor cells were found to be required for liver regeneration following surgical removal, shedding light on liver complications associated with suppressed bone marrow tissue.
A Michigan State University anthropologist has exposed the horrific experiences of poor people who were victims of organ trafficking. Moniruzzaman's study found that kidney sellers are often plagued with health problems and receive inadequate compensation.
A small study of 25 patients with hereditary hemorrhagic telangiectasia found improved cardiac output and reduced duration and number of episodes of nose bleeds after receiving bevacizumab. The treatment also significantly improved quality of life, with moderate toxicity observed.
Researchers at the University of Edinburgh have discovered a way to increase hepatocyte cells, which detoxify the liver, by encouraging their production instead of bile duct cells. This breakthrough could help develop drugs to encourage liver self-repair and ease pressure on waiting lists for liver transplants.
Researchers found that induced hyperammonaemia significantly increases daytime sleepiness in patients with cirrhosis. Higher blood ammonia levels reduce the ability of cirrhotic patients to produce restorative sleep. This study suggests that reducing daytime sleepiness may result in improved sleep at night.
A recent study published in Liver Transplantation confirms that ultrasound-based transient elastography is an effective diagnostic tool for detecting cirrhosis caused by recurrent hepatitis C following liver transplantation. The non-invasive technology offers quick and painless assessment, with high sensitivity and specificity estimates.
Researchers created a new method using calculus equations to estimate acetaminophen overdose patient prognosis, predicting those who can survive with antidote treatment versus those needing a liver transplant. The study analyzed 53 patients and showed the method's accuracy in determining survival outcomes.
Researchers have overturned a 'textbook' view of liver metabolism, revealing a backup pathway that governs glucose production. The discovery suggests new targets for diabetes drugs and may help bypass the block in insulin action that occurs in Type 2 diabetes.
The UK is projected to see up to 210,000 avoidable alcohol-related deaths over the next 20 years, including 70,000 from liver disease. The government can take action to prevent this by implementing evidence-based measures such as increasing prices and reducing availability.
A study published in Nature suggests that faulty fat sensor GPR120 may contribute to obesity and liver disease. Mice deficient in GPR120 are more prone to developing these conditions when fed a high-fat diet, highlighting the protein as a promising target for new treatments.
Research reveals that cirrhosis patients losing muscle mass have a significantly shorter survival rate than those with normal muscle mass. The study's findings suggest that muscle mass should be considered alongside current scoring systems when assessing transplant list placement.
The guidelines describe best practice for the diagnosis and treatment of patients with Wilson's disease, a rare genetic disorder that can cause liver failure and brain damage. Treatment options include chelating agents and zinc, with prolonged survival becoming the norm for patients.
Research published in Hepatology found that moderate coffee consumption decreases the risk of advanced fibrosis in NASH patients. The study also showed a significant correlation between coffee intake and reduced risk of hepatic fibrosis, particularly among patients with NASH stage 0-1.
Researchers found that rituximab, a monoclonal antibody, was safe and effective in reducing liver damage in PBC patients who had an incomplete response to UDCA therapy. The study showed significant reductions in alkaline phosphatase levels and anti-mitochondrial antibodies after treatment.
A pilot study found that 60% of children who received liver tissue from a parent can safely discontinue immunosuppression. The study identified three clinical factors that predict which pediatric liver transplant patients are most likely to do well if the medications are withdrawn.
A study in zebrafish reveals that a gene mutation affects ketone body transport, leading to lipid accumulation in the liver. This discovery provides new insights into nonalcoholic fatty liver disease (NAFLD) and its link to energy metabolism.
Researchers found that cardiopulmonary exercise testing (CPET) is a significant predictor of mortality in patients after liver transplantation. The study showed that patients with higher fitness levels had lower mortality rates, making CPET a valuable tool for assessing liver transplant candidates.
Researchers aim to create a predictive model for liver metabolism using cellular control of fat metabolism as an optimal feedback-control system. The goal is to analyze and optimally compute possible interventions for treating fatty livers, leading to personalized medicine approaches.
Research from Michigan Medicine shows a 15% increase in post-liver transplant kidney failure among recipients since the implementation of Model of End Stage Liver Disease (MELD) allocation. Modifiable risk factors identified include African American race, hepatitis C, and pre-transplant diabetes.
Researchers at UBC have found a way to block infection from the hepatitis C virus (HCV) in the liver, leading to new therapies for those affected by this and other infectious diseases. The approach could benefit millions of people globally.
Researchers have discovered a way to block cell-to-cell communication in the liver, preventing damage caused by toxic drugs like acetaminophen. The approach has potential for improving drug safety and could lead to new treatment options for patients with drug-induced liver injury.
Researchers have found a way to protect the liver from damage caused by certain drugs, which could lead to improved drug safety. By targeting gap junctions in liver cells, they hope to develop new therapies for treating patients with drug-induced liver injury.
Patients with cirrhosis are more likely to be Hispanic, have lower education, and higher healthcare utilization. They also experience significant functional disability, requiring twice the amount of informal caregiving as non-cirrhotic peers.
A new classification for diagnosing fibrosis in patients with chronic HCV has shown to be as accurate as currently used algorithms, but required no further liver biopsy. The study combined two fibrosis tests, providing a non-invasive and more precise fibrosis diagnosis.
A study published in Hepatology found that older Americans with cirrhosis require twice the amount of informal caregiving and contribute added strain on the healthcare system. The prevalence of cirrhosis is expected to climb in this frail population due to increasing obesity and aging of those with hepatitis C.
A UCSF-led study found that children with biliary atresia who received maternal liver grafts had a failure rate of 3.7%, compared to 10.5% for paternal grafts. The researchers believe higher levels of maternal cells may establish tolerance and acceptance of maternal organs.
Nonalcoholic steatohepatitis (NASH) is rapidly increasing in the U.S., mainly related to obesity and diabetes. Researchers found excellent post-transplantation survival rates among NASH patients, with one-year survival rates near 88%.
A team of researchers has identified markers that may enable liver transplant recipients to be weaned off their immunosuppressive drugs. Higher blood levels of iron-handling proteins and specific gene expressions in the liver can predict which patients are suitable for drug-weaning protocols.
Researchers at Boston University School of Medicine have identified the A2b adenosine receptor as a potential new target for preventing early stages of atherosclerosis. The study found that the receptor plays a key role in regulating liver lipid profiles and reducing atherosclerosis in mice on high-fat diets.
Researchers found that patients with fatty livers burn more fat and produce glucose faster than those with healthy livers, potentially leading to organ damage. The study's findings challenge previous assumptions about the role of metabolism in fatty liver disease.
A study found that green tea flavonoid EGCG inhibits the entry of hepatitis C virus into liver cells, suggesting a potential antiviral strategy to prevent reinfection following liver transplantation. The researchers investigated the effect of EGCG on HCV in preventing attachment and spread within liver cells.
A study published in Liver Transplantation reveals that liver transplant candidates prioritize 'best quality' organs over those with a higher risk of failure. The study found that patients prefer to have an equal or dominant role in deciding organ acceptance, and presenting organ quality as 'average quality' can increase risk tolerance.
Patients on liver transplant waiting lists prefer to receive high-quality donor organs, even if it means waiting longer, according to a new study. The research found that 58% of candidates would only accept organs with a risk of graft failure of 25% or less.
Recent studies have uncovered significant limitations in liver cancer screening for patients with cirrhosis, emphasizing the need for enhanced diagnostic procedures. Most patients with cirrhosis prefer surveillance over non-screening, and ultrasonographic screening at different intervals did not improve detection of small liver cancers.
Researchers at Newcastle University discovered that manipulating serotonin's actions can tip the balance towards healthy tissue regeneration and block scarring in mouse models of chronic liver disease. This approach targets the 5-HT2B receptor, which instructs scar-forming cells to switch off regeneration.
A new study by Johns Hopkins researchers found no correlation between non-alcoholic fatty liver disease (NAFLD) and increased mortality. NAFLD, prevalent among those with heart disease and obesity, does not appear to undermine health and longevity.
Repeatedly taking slightly too much paracetamol over time can lead to a dangerous staggered overdose. Patients with staggered overdoses often have low levels of paracetamol in their blood despite being at high risk of liver failure and death, according to Dr Kenneth Simpson.
A team of scientists from Scripps Research Institute has identified a family of chemical compounds that could lead to the development of novel drugs capable of not only alleviating symptoms but also preventing the deadly disease. The new class of compounds is highly effective against malaria parasites in both the blood and liver stages.
Researchers at Novartis have discovered a new class of dual-acting antimalarial compounds, the imidazolopiperazines (IZPs), which target both liver and blood infections. These compounds attack the Plasmodium parasite at both stages in its reproduction cycle, showing promise as a next-generation treatment for malaria.
A recent study by Marshall University researchers discovered that nanoparticles of cerium oxide, commonly used in diesel fuels, can travel from the lungs to the liver and cause damage. The study found a dose-dependent increase in cerium levels in the liver, associated with liver enzyme elevations and histological evidence of liver damage.
Researchers have identified a new class of compounds, known as the imidazolopiperazine (IP) cluster, that could target both liver and blood stages of malaria infection. The IP cluster, including compound GNF179, showed promise in treating malaria-infected mice, extending survival by an average of 19 days.
Higher quality livers come from ducks with active fat-storing cells, while lower quality livers have cells struggling with high fat levels. Analyzing liver proteins revealed a key factor in determining foie gras quality.
A new treatment combining corticosteroids and N-acetylcysteine improves survival rates for patients with acute alcoholic hepatitis by 35-40% within a month, compared to the conventional cortisone-based treatment. The study results show that this combination therapy is well-tolerated and offers a promising prognosis for severe alcoholic...
Researchers at Henry Ford Hospital found that adult living donor liver transplants are safe with a 100% donor survival rate and low-grade complications. The study, which looked at 54 living donor liver transplants over 10 years, also found minor complications in 61% of donors.
Researchers at Cincinnati Children's Hospital Medical Center have identified a new molecular signature for biliary atresia, a devastating pediatric liver disease. The study found that some children with the condition exhibit high levels of Th2 immune system activity, providing a potential target for new therapies.
A human monoclonal antibody significantly suppressed hepatitis C virus (HCV) levels in liver transplant patients, delaying viral rebound. The treatment also reduced HCV-related liver damage and improved patient outcomes.
A study by Henry Ford Hospital found that patients with advanced liver disease have significantly higher healthcare costs compared to those with early stages of the disease. The average annual cost for patients with end-stage liver disease was estimated to be $59,995.
Researchers at the University of North Carolina Health Care have identified the regulatory mechanism behind cell polyploidy, a phenomenon observed in plants and insects. The discovery may lead to new insights into liver regeneration and disease treatment.
Researchers at UCLA have developed a promising new treatment for iron overload disorders using minihepcidin peptides, which mimic the natural protein hepcidin to lower iron levels in the blood. The study provides hope for individuals affected by hereditary hemochromatosis and beta-thalassemia.
Researchers discovered that insulin signaling converges with nutrient metabolism pathways to regulate lipid synthesis in the liver. The study suggests that multiple pathways are required for insulin-resistant livers to accumulate lipids.
The genome sequencing of Clonorchis sinensis reveals that it lacks enzymes required for fatty acid biosynthesis, unlike other liver flukes. This discovery provides insight into the parasite's complex lifestyle and may lead to new ways of controlling diseases caused by this parasite.
Differences in two metabolic enzymes may explain susceptibility to liver damage. Low levels of GAPDH and NDPK are associated with increased oxidative stress and disease severity.
A new study has identified 42 genetic regions associated with liver function, providing a better understanding of liver damage and disease. The research, involving over 61,000 people, may lead to new treatments that can improve liver function and prevent liver damage.
Scientists have cleanly corrected a human gene mutation in a patient's stem cells, using cutting-edge methods to target and correct the sequence of the genome. The corrected gene worked normally, demonstrating the potential for patient-specific therapies.
Studies reveal the role of Sirt1 in improving insulin sensitivity through caloric restriction. Researchers also identify a potential treatment approach for KRAS mutant colorectal cancers by combining receptor tyrosine kinase inhibitors with MEK inhibitors. Additionally, new insights into the cellular defects of Huntington disease are p...
A new inherited neurometabolic disorder has been discovered, caused by mutations in the ADK gene. The disease, adenosine kinase deficiency, disrupts the methionine cycle, leading to symptoms such as encephalopathy and abnormal liver function.
Researchers found that high-volume transplant centers used more high-risk donor livers, but achieved better graft and recipient survival rates. The study's findings suggest that increased organ utilization can improve outcomes for transplantation patients.
Researchers at the University of Pittsburgh have identified a powerful molecular pathway regulating the liver's insulin management and new glucose production. FOX06, a protein family member, plays a crucial role in glucose production, leading to improved blood sugar levels when inhibited.
Researchers at UCLA developed a risk scoring system to predict long-term survival after liver re-transplantation, identifying eight key risk factors for potential failure. The predictive index will help guide physicians in determining patient risk and provide patients with informed consent information.